Western Australian Psychotropic Drugs Committee - WAPDC

Guidelines and Information


Graylands Hospital Drug Bulletin


Main Topic Vol. No. Month Year
Venous Thromboembolism and Antipsychotics 21 3 December 2015
Vortioxetine 22 2 October 2015
Focus on Benzodiazepines 22 1 March 2015
Using lithium safely 21 4 December 2014
Aripiprazole long-acting injection 21 3 September 2014
Clozapine Initiation Chart 21 2 June 2014
Extrapyramidal Side Effects 21 1 March 2014
Emerging Psychoactive Substances 20 4 December 2013
Effect of smoking and caffeine 20 3 October 2013
Antipsychotic polypharmacy 20 2 July 2013
Antidepressant switching 20 1 March 2013
Psychotropics + pregnancy 19 2 August 2012
Asenapine 19 1 March 2012
Cytochromes and antipsychotics 18 3 December 2011
Psychostimulants 18 2 July 2011
New Antipsychotics 18 1 March 2011
Cardiac Adverse Effects 17 2 December 2010
Complementary Medications 17 1 August 2010
Long Acting Antipsychotic Injections 16 4 December 2009
Pharmacological Treatment of Bipolar Disorder 16 3 October 2009

Metabolic Syndrome, Prolactin Elevation

16

2

June

2009

Desvenlafaxine and Duloxetine: new antidepressants

16

1

March

2009

Antidepressant combination and augmentation 15 4 October 2008
Paliperidone 15 4 June 2008
Antipsychotic Combinations 15 3 February 2008
Smoking Cessation in Psychiatric Patients 15 2 July 2007
Ziprasidone Unzipped 15 1 March 2007
CATIE and Typical Antipsychotics 14 4 December 2006
Antipsychotic Monitoring 14 3 October 2006
Psychotropic drug interactions 14 2 July 2006
Antipsychotic switching: When, how, why? 14 1 March 2006
Management of clozapine-induced side-effects 13 4 December 2006
Treatment of antipsychotic-induced weight gain 13 3 October 2005
New Anticonvulsants as Mood Stabilisers 13 2 June 2005
Metabolic disturbances with antipsychotics 13 1 March 2005
Lithium revisited – frequently asked questions 12 4 December 2004
Clozapine & gastrointestinal adverse effects 12 3 September 2004
Atomoxetine – how useful for ADHD? 12 2 July 2004
Clozapine augmentation 12 1 March 2004
Aripiprazole – a new class of antipsychotic? 11 4 November 2003
Lithium induced hypothyroidism. When to treat? 11 3 June 2003
Risperdal Consta 11 2 May 2003
Combining antidepressants 11 1 February 2003
Reboxetine – a'NaRI' 10 3 November 2002
Profile of amisulpride 10 2 July 2002


Back to Top

Statewide Psychiatric Drug Information Centre

The Statewide Psychiatric Drug Information Centre is a pharmacist-led service that responds to psychiatric drug information enquiries from healthcare professionals throughout Western Australia. In addition to offering practical advice on drug therapy, literature searches and evaluations of evidence-based practice are also provided.

Enquiries can be made by phoning (08) 9347 6400 between 8.30am and 4.30pm Monday to Friday.

Enquiries via email are also welcome.  Contact the Statewide Psychiatric Drug Information Centre at: druginformation.graylands@health.wa.gov.au

File Formats
The documents for download on this website are in a Portable Document Format (PDF). To read these files you might need to download Adobe® Acrobat Reader.

Get Adobe® Reader